Results 151 to 160 of about 13,218 (187)

Retraction Statement: Atypical parkinsonism and self-mutilation: A new lens on the old concept. [PDF]

Clin Case Rep, 2023
europepmc   +1 more source

Rapid generation of prion disease models using AAV‐delivered PrP variants in knockout mice

Brain Pathology, Volume 36, Issue 4, July 2026.
We developed a rapid AAV‐based system to generate prion disease models in weeks rather than months. Following systemic AAV9P31 delivery of modified PrP to knockout mice, we achieved brain‐wide expression and successful propagation of both classical (RML) and atypical (GSS‐A117V) prion strains.
Maitena San‐Juan‐Ansoleaga, Eva Fernández‐Muñoz, Jorge M. Charco, Enric Vidal, Diego Herrero‐Martínez, Josu Galarza‐Ahumada, Cristina Sampedro‐Torres‐Quevedo, Samanta Giler, Mariví Geijo, Gloria González‐Aseguinolaza, Hasier Eraña, Joaquín Castilla   +11 more
wiley   +1 more source

Psychedelics, entactogens and psychoplastogens for depression and related disorders

British Journal of Pharmacology, Volume 183, Issue 14, Page 3897-3919, July 2026.
Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley   +1 more source

Use of Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 5767-5778, July 2026.
ABSTRACT Aims To investigate the association between use of GLP‐1 receptor agonists and incident Parkinson's disease. Material and Methods Cohort study using data from nationwide registers in Denmark, Norway and Sweden and an active‐comparator, new‐user design.
Arvid Engström, Henrik Svanström, Anders Hviid, Björn Eliasson, Soffia Gudbjörnsdottir, Viktor Wintzell, Kristian Hveem, Christian Jonasson, Mads Melbye, Peter Ueda, Björn Pasternak   +10 more
wiley   +1 more source

The Spectrum of Cognitive Impairment in Atypical Parkinsonism Syndromes: A Comprehensive Review of Current Understanding and Research. [PDF]

Diseases
Jellinger KA.
europepmc   +1 more source

Analysis of C9orf72 repeat length in progressive supranuclear palsy, corticobasal syndrome, corticobasal degeneration, and atypical parkinsonism. [PDF]

J Neurol
Vaughan DP, Real R, Jensen MT, Fumi RG, Hodgson M, Jabbari E, Lux D, Wu L, PROSPECT consortium, MD-GAP, Warner TT, Jaunmuktane Z, Revesz T, Rowe JB, Rohrer J, Morris HR.   +15 more
europepmc   +1 more source

Autoimmune "Atypical" Atypical Parkinsonism: Anti-GABA_B Receptor Encephalitis Presenting as a Reversible Mimic of Progressive Supranuclear Palsy. [PDF]

Mov Disord Clin Pract
Mustafa F, Rajanna C, Agarwal A, Garg A, Srivastava AK, Mahadevan A, Garg D.   +6 more
europepmc   +1 more source

Editorial: Multimodality imaging techniques in PD and atypical Parkinsonism. [PDF]

Front Neurol
Song T, Nie B.
europepmc   +1 more source

Upper motor neuron-predominant motor neuron disease presenting as atypical parkinsonism: A clinicopathological study. [PDF]

Brain Pathol
Murakami A, Koga S, Fujioka S, White AE, Bieniek KF, Sekiya H, DeJesus-Hernandez M, Finch NA, van Blitterswijk M, Nakamura M, Tsuboi Y, Murray ME, Wszolek ZK, Dickson DW.   +13 more
europepmc   +1 more source